No Detail Found!

Elevated Exhaled Nitric Oxide (NO) in asymptomatic asthmatics taking bronchodilators on demand with controlled body composition.

Author(s)
Shahid Habib Syed Department of Physiology, King Khalid University Hospital, College of Medicine, Riyadh, Kingdom of Saudi Arabia
Abstract
Objective: Fractional Exhaled Nitric Oxide (FENO) is a recently introduced non invasive marker to measure inflammation and oxidative stress in the lung. This study aimed to measure FENO in Saudi asthmatic adult patients who had mild to moderate persistent asthma, on inhaled short-acting ? 2 agonists and compared them to healthy individuals matched for body composition without any evidence of obstructive airway disease. Methods: As per selection criteria 61 subjects were selected. 30 subjects were known asthmatic and 31 were healthy individuals matched for age, height, weight, BMI and body composition. Forced expiratory volume in 1 s (FEV1), FVC, FEV1/ FVC, PEF, FEF25, FEF50 and FEF75 were measured by standard methods. FENO measurements were performed according to the ATS (American Thoracic Society) recommendations. Results: Ventillatory function parameters FEV1 (p=0.0020), FVC (p=0.0030), PEF (p=0.0121), FEF25 (p=0.0241), FEF50 (p=0.0240) and FEF75 (p=0.1824) were significantly lower in asthmatic subjects compared to matched healthy control group. FENO was significantly higher (82.51 ± 39.26) in asthmatic subjects compared to control group (23.03 ± 8.56) p
Publication Details
Page(s) 147-150
DOI DOI not available
Published Journal: Journal of Pakistan Medical Association, Volume: 59, Issue: 3, Year: 2009

Request the full text from PASTIC

0

Citations

0

Downloads

73

Views